CARTICEPT MEDICAL™ ANNOUNCES $20 MILLION SERIES B FINANCING
Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $20 million Series B financing round.
New investor SonoSite, Inc. joined existing investors Domain Associates and New Enterprise Associates.
Read More  |
 |
Cartiva SCI is designed to replace or repair worn or damaged cartilage. The proprietary implant mimics natural cartilage and is intended to maintain natural joint mechanics.
Learn More 
|
The Navigator DS is an integrated, computer-controlled fluid delivery system designed to automate delivery of medications and other fluids.
Learn More  |
|